Blueprint library/AD

Pharmaceutical Analytical Development Software

From analytical target profile to a transferable, controlled method—with the learning intact.

Analytical target profiles, experiments, method parameters, chromatographic and spectral evidence, forced degradation, robustness, control strategy, validation readiness, transfer, and lifecycle knowledge connected to ELN, SDMS, LIMS, instruments, and standards.

Pharmaceutical Analytical Development Software

The method that worked until it didn't

The HPLC method worked perfectly in development. Good separation, sharp peaks, reproducible results. Method validation passed all criteria. Then it transferred to QC.

Different column lot. Slightly different room temperature. The separation shifted. Peaks that were baseline-resolved now overlapped. QC couldn't match development's results. The investigation took weeks. Was it the method, the analyst, the equipment? The answer was in the development data, but finding it meant searching through notebooks and printouts.

Method development and method execution are different activities. But when they happen in different systems, the knowledge generated during development doesn't carry forward. The method that worked becomes the method that doesn't, and nobody knows why.

Method Transfer Flow
Fig. 1 / Method Transfer Flow

Development with structure

Analytical development requires flexibility. Scientists need to iterate. Try different columns, adjust gradients, optimize detection. Forcing rigid GMP controls on early development kills productivity and misses insights.

But flexibility doesn't mean chaos. Seal provides structured flexibility: scientists can iterate freely, but their iterations are captured systematically. When they change a column, the change is recorded. When they optimize a gradient, the optimization path is preserved. The flexibility is in the execution. The structure is in the capture.

Method parameters as data

Most method development documentation answers "what works?" The final method is documented. The parameters that produced good results are recorded. But the parameters that didn't work, the alternatives tried, the reasoning behind choices. These live in notebooks, emails, and memories.

Seal captures method parameters as structured data throughout development. Every column tested. Every gradient tried. Every detection setting evaluated. When the final method is established, it's not isolated. It exists in context of everything that was tried. When QC can't reproduce results, you can see exactly what parameters development used, and exactly how they compare to what QC is running.

Validation linked to development

Method validation proves the method works for its intended purpose. Specificity, linearity, accuracy, precision, robustness. Each criterion requires evidence. In most organizations, validation is a separate project: development hands off a method, validation tests it, results go into a report.

Method Validation Linkage
Fig. 2 / Method Validation Linkage

Seal links validation to development. The method being validated is the same method object that was developed. Validation studies reference the development parameters. When specificity is demonstrated, it's linked to the method's separation characteristics. When robustness is tested, the parameter variations connect to what development learned about sensitivity.

Transfer without translation

Method transfer is where knowledge dies. Development documents the method. QC receives the document. QC implements their version of the method. If results don't match, someone has to figure out whether the difference is in the method, the equipment, the analysts, or the documentation.

Seal eliminates translation by keeping development and QC on the same platform. The method development created is the method QC executes. Transfer isn't sending documents. It's promoting a method object from flexible mode to controlled mode. Parameters tighten. Controls enable. But the method itself doesn't change.

Stability-indicating capability

Stability-indicating methods require specific evidence: forced degradation studies that prove the method detects breakdown products. In most organizations, these studies are documented separately from the method. Reports that reference the method but aren't linked to it.

Seal connects stability-indicating evidence to method definitions. Force degradation studies are structured data. The degradation products identified are linked to the method's specificity. When the method moves to stability testing, the evidence that supports its suitability travels with it.

Instrument method consistency

The HPLC method has parameters. The instrument has parameters. When these don't match exactly, results vary. In paper-based systems, someone transcribes method parameters to instrument settings. Transcription errors cause variability.

Seal integrates method parameters with instrument control. When a method runs, the instrument receives parameters from the method definition. Not from an analyst's interpretation of a document. The column specification, flow rate, gradient program. All configured from the method, eliminating transcription variation.

Reference standards with qualification data

Every analytical method needs reference standards. Primary standards, working standards, system suitability solutions. Each with qualification data, expiration dates, storage requirements. In most organizations, standard management is separate from method execution. Standards are tracked in one system, used in another, and linked by someone remembering to record the lot number.

Seal links reference standards to methods and executions. When a method runs, it specifies which standards are required. When an analyst prepares and uses a standard, the qualification status is verified, the usage is recorded, and the link to results is automatic. When a standard expires or requalification is due, the system knows. And the methods that depend on it know too.

Method lifecycle management

Methods evolve. A method optimized during early development may need refinement as the product matures. Specifications tighten. Impurity profiles clarify. Regulatory feedback requires changes. Managing these changes. And maintaining the connection between method versions and the data they generated. Is complex.

Seal versions methods with full lifecycle tracking. When you modify a method, that's a new version with defined changes. Historical data links to the method version that generated it. When you need to understand why results differ between studies, you can see exactly what method version was used for each. The method's evolution is documented, not reconstructed.

Compendial method qualification

Compendial methods. USP, EP, JP. Provide standardized procedures. But implementing them requires qualification: proving the method works in your hands, with your equipment, for your product. Most organizations document this qualification separately from the method itself.

Seal links compendial methods to their qualification studies. The USP method you're implementing has defined parameters. Your qualification study demonstrates those parameters work in your laboratory. When you execute the method, it traces to both the compendial reference and your site-specific qualification. When compendial updates occur, impact assessment is straightforward. Because you know exactly what you qualified.

Analytical data integrity

21 CFR Part 11 and data integrity requirements apply to analytical development just as they do to QC. Original data must be preserved. Changes must be documented. Audit trails must be complete. But development labs often operate with less rigor than QC. Paper notebooks, uncontrolled spreadsheets, data copied between systems.

Seal applies consistent data integrity across development and QC. Electronic records are preserved. Audit trails capture changes. When development data supports regulatory submissions, the integrity is built in. Not retrofitted during submission preparation. Development scientists work efficiently; the system handles compliance.

The analytical target profile defines success first

Intended use, reportable attributes, analytes, product and matrix, specification or decision range, sensitivity, selectivity, accuracy, precision, reportable range, sample constraints, turnaround, lifecycle phase, and risk establish what the method must accomplish.

Candidates are compared against that target rather than optimized toward whichever signal looks best. Changes to intended use reopen the relevant evidence.

Experiments preserve factors, responses, and conclusions

Purpose, hypothesis, method version, samples, standards, factors, levels, run order, instrument, materials, conditions, observations, source data, processing, responses, exclusions, model, interpretation, conclusion, and next decision form the experiment.

Failed and ambiguous trials remain searchable. That negative knowledge prevents future teams from repeating unsuitable columns, preparations, transitions, gradients, or processing choices.

Forced degradation connects chemistry to selectivity

Stress agent, level, temperature, light, humidity, timepoint, control, quench, sample preparation, chromatographic or spectral evidence, mass balance, peak purity, degradant identity, pathway, coelution risk, and conclusion remain connected.

The result is not merely a report that degradation occurred; it is an evidence chain showing whether the method can distinguish the product-relevant change it claims to measure.

Robustness defines a control region

Risk assessment selects factors likely to influence reportable results. Designed experiments capture ranges, interactions, nonlinearities, edge behavior, system-suitability response, sample and solution stability, analyst and equipment effects, and method failure modes.

The approved method receives justified set points, allowed ranges, critical checks, and suitability criteria. Knowledge outside that region remains available for investigations and future changes.

Validation readiness is a real gate

Before formal validation, Seal evaluates intended use, method definition, sample and standard procedures, calculations, specifications, selectivity, range, preliminary performance, robustness, instrument needs, reference materials, data capture, training, risks, deviations, and open knowledge gaps.

Ready, ready with conditions, or not ready decisions retain the evidence, conditions, owner, due date, and approval.

The boundary with method lifecycle controls is clear

Analytical development owns target profiles, experiments, candidate methods, parameter learning, degradation and robustness knowledge, and selection decisions. The analytical method lifecycle blueprint governs formal validation, transfer, controlled change, continued performance verification, revalidation, and retirement.

ELN captures experimental work, SDMS preserves source analytical data, LIMS runs controlled laboratory methods, equipment records establish instrument state, and standards management controls reference and reagent suitability. Seal composes them without collapsing their responsibilities.

Seal is strongest when the method leaves development

The approved parameter does not arrive in QC as an isolated sentence. It carries the explored range, factor effects, failure modes, source data, sample and standard requirements, control strategy, validation basis, receiving-site differences, and performance signals.

When a transfer or routine run behaves differently, teams can compare actual execution with the method's evidence-backed operating region instead of searching old notebooks.

Operating model

The control layer sits above the systems that supply governed records and execution.
Control layer

Owned by this blueprint

Live state and point-of-use decisions

  • Structured Method Development
  • Force Degradation Studies
  • Method Versioning
  • Compendial Method Support
  • Analytical Data Integrity
  • Method Lifecycle Dashboard

Capabilities

01native controlStructured Method Development
Flexible iteration with systematic capture. Every parameter change recorded. Development context preserved.
02Methodsconnected foundationLinked Validation
Validation studies connected to method definitions. Evidence traces to what was actually validated.
03Transfer Without Translation
Promote methods from development to QC. Same method, tightened controls. No document translation.
04native controlForce Degradation Studies
Stability-indicating evidence linked to methods. Degradation products documented systematically.
Standards linked to methods with qualification status. Usage tracked automatically. Expiration managed proactively.
06native controlMethod Versioning
Full lifecycle tracking. Historical data links to the method version that generated it. Evolution documented.
07native controlCompendial Method Support
Link USP, EP, JP methods to site-specific qualification. Compendial updates with clear impact assessment.
08equipmentconnected foundationInstrument Integration
Method parameters push to instruments. Results pull back automatically. No transcription, no variation.
09native controlAnalytical Data Integrity
Part 11 compliant audit trails across development and QC. Original data preserved, changes documented. Submission-ready without retrofitting.
10native controlMethod Lifecycle Dashboard
Track every method from early development through validation, transfer, and routine use. See status, version history, and upcoming revalidation dates at a glance.

Entities

Entity hierarchy
What it records
Kind
Analytical Method
The procedure that measures quality. Developed with flexibility, locked for QC.
entity
Stability-Indicating Method
Proves degradation detection. Force degradation studies linked to method parameters.
template
Chromatographic Method
Separation, column, mobile phase, gradient, flow, temperature, detection, integration, suitability, and calculation definition.
template
AM-104 / Rev 7
Stability-indicating assay and impurity method with approved parameter ranges, processing, suitability, and intended use.
record
Method Parameter
Column, mobile phase, flow rate, detection. Captured during development, enforced in production.
entity
Method Validation
Proof the method works. Specificity, linearity, accuracy, precision. Linked to the method, not buried in reports.
entity
Method Transfer
Development to QC. Same platform, tightened controls. No rewriting, no translation.
entity
Analytical Target Profile
Intended purpose, reportable attributes, product and matrix, range, performance needs, risks, lifecycle stage, and approval.
entity
Method Experiment
Purpose, factors, levels, run order, samples, instruments, materials, observations, raw data, results, and conclusion.
entity
Forced Degradation Study
Stress conditions, controls, timepoints, mass balance, degradants, peak purity, pathway, selectivity, and conclusion.
template
Method Robustness DoE
Risk-selected factors, ranges, design, responses, models, interactions, edges, failure modes, and control-region conclusion.
template
EXP-AM104-0082
Column temperature, flow and buffer-pH study identifying a pH-by-temperature interaction and justified operating region.
record
Development Sample
Material, batch, matrix, preparation, treatment, concentration, storage, chain of custody, and use.
entity
Analytical Raw Data
Instrument files, sequence, injections, spectra or chromatograms, processing method, audit trail, review, and retained source.
entity
Method Knowledge Claim
Evidence-backed conclusion about selectivity, sensitivity, factor effect, failure mode, range, interaction, or operable region.
entity
Analytical Control Strategy
Controlled sample, preparation, instrument, parameter, suitability, calculation, standard, acceptance, and exception rules.
entity
Validation Readiness Decision
Evidence gate covering intended use, method definition, risks, performance, robustness, standards, calculations, data, and unresolved gaps.
entity
VAL-READY-AM104
Approved readiness decision with selectivity, robustness, standard, calculation, sample-stability and data-integrity evidence.
record
Method Performance Signal
System suitability, precision, recovery, resolution, bias, invalid rate, OOS attribution, trend, threshold, assessment, and action.
entity

FAQ

Yes. The structure captures their work. It doesn't constrain it. Scientists iterate on parameters, and the system records what was tried. Freedom in exploration, discipline in documentation.
You promote the method from development to QC. Same method definition, same platform. Transfer protocols can compare results between labs using the same underlying method. Not different interpretations of a document.
Reference standards link to methods and validation studies. When a standard is used, it's recorded with traceability to the method and the qualification status of the standard.
Methods developed in Seal promote directly to QC execution. The method QC runs is the method development created. Same parameters, same specifications, enforced by the system.
Direct integration with major analytical platforms. Waters, Agilent, Thermo Fisher, Shimadzu. For other instruments, we support standard data formats and can build custom connectors. The goal is bidirectional communication: parameters out, results back.
Validation studies are structured around ICH Q2 criteria. Specificity, linearity, accuracy, precision, range, robustness. Each criterion links to the studies that demonstrate it. The validation report pulls from structured data, not assembled documents.
The method definition is the same across sites. Transfer protocols execute at each receiving site, comparing results to the originating site. Equivalence is demonstrated with the same underlying method. Differences are in execution, not interpretation.
Yes. The same data integrity controls apply to development and QC. Audit trails, electronic signatures, access controls. All built in. When development data supports regulatory submissions, compliance is already there.
Development data is structured and audit-trailed from the start. When you prepare an IND, NDA, or BLA, the method development history, validation evidence, and transfer results are already organized and traceable. No last-minute scramble to reconstruct what happened.
Yes. System suitability results, resolution, and other performance indicators are tracked across runs. When a method starts drifting, you see it in the trend before it fails a system suitability check. Proactive intervention instead of reactive investigation.

Related blueprints

PC

Pharmaceutical Process Characterization Software

Manage process characterization strategy, prior knowledge, risk assessments, DoE and edge-of-failure studies, parameter-to-quality relationships, scale and platform models, proven ranges, design-space claims, control-strategy decisions, and validation handoff.

E&L

Pharmaceutical Extractables & Leachables (E&L) Management Software

Map product-contact systems, characterize materials, plan extractables and leachables studies, calculate exposure and analytical evaluation thresholds, identify compounds, govern toxicological assessments, justify bracketing, and manage lifecycle change.

Nitrosamines

Pharmaceutical Nitrosamine Risk Assessment & Control Software

Govern product and API nitrosamine risk assessments, amine and nitrosating-agent knowledge, formation pathways, acceptable-intake limits, confirmatory methods and testing, mitigation, stability, supplier dependencies, regulatory reporting, and lifecycle review.

PD

Pharmaceutical & Bioprocess Development Software

Product and process targets, unit operations, materials, experiments, parameters, scale models, yields, samples, quality attributes, knowledge claims, process candidates, maturity gates, and transfer readiness connected across ELN, LIMS, equipment, characterization, and tech transfer.

UD

Bioprocess Upstream Development Software

Run cell-culture and fermentation development with governed cell lineage, media and feed versions, executable recipes, connected bioreactors, samples and assays, clone and process comparisons, scale-up models, perfusion state, harvest decisions, characterization, and technology transfer.

DD

Bioprocess Downstream Development Software

Run purification and formulation development with governed harvest inputs, buffers and solutions, chromatography and filtration methods, column and membrane lifecycle, fractions and pools, samples and assays, yield and clearance balances, holds, scale-up models, characterization, and technology transfer.

Go live in 48 hours.